Advertisement
Advertisement

WGS

WGS logo

GeneDx Holdings Corp. Class A Common Stock

135.52
USD
Sponsored
-1.95
-1.42%
Jan 09, 15:59 UTC -5
Closed
exchange

After-Market

137.72

+2.21
+1.63%

WGS Earnings Reports

Positive Surprise Ratio

WGS beat 12 of 17 last estimates.

71%

Next Report

Date of Next Report
Feb 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
$121.58M
/
$0.10
Implied change from Q3 25 (Revenue/ EPS)
+4.14%
/
-79.59%
Implied change from Q4 24 (Revenue/ EPS)
+27.12%
/
-83.87%

GeneDx Holdings Corp. Class A Common Stock earnings per share and revenue

On Oct 28, 2025, WGS reported earnings of 0.49 USD per share (EPS) for Q3 25, beating the estimate of 0.42 USD, resulting in a 14.73% surprise. Revenue reached 116.74 million, compared to an expected 105.72 million, with a 10.43% difference. The market reacted with a +5.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of 0.10 USD, with revenue projected to reach 121.58 million USD, implying an decrease of -79.59% EPS, and increase of 4.14% in Revenue from the last quarter.
FAQ
For Q3 2025, GeneDx Holdings Corp. Class A Common Stock reported EPS of $0.49, beating estimates by 14.73%, and revenue of $116.74M, 10.43% above expectations.
The stock price moved up 5.21%, changed from $130.66 before the earnings release to $137.47 the day after.
The next earning report is scheduled for Feb 16, 2026.
Based on 10 analysts, GeneDx Holdings Corp. Class A Common Stock is expected to report EPS of $0.10 and revenue of $121.58M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement